ArticleJHLT open2026
Surgical venous-to-pulmonary artery temporary right ventricular support after durable left ventricular assist device implantation: A single-center experience.
Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative right heart failure (RHF) remains a major complication after durable left ventricular assist device (LVAD) implantation and is associated with substantial morbidity, mortality, and resource utilization. Temporary right-sided mechanical circulatory support strategies are increasingly used for severe RHF, but comparative real-world data remain limited. We evaluated the incidence of postoperative RHF after durable LVAD implantation, its association with early outcomes, and institutional RHF treatment patterns. Methods: We performed a retrospective single-center cohort study of 79 consecutive adult patients who underwent durable LVAD implantation at Oklahoma Heart Institute between January 2018 and April 2026. Patients were categorized by the presence or absence of postoperative RHF. The primary analysis compared early postoperative outcomes between RHF and non-RHF groups. Continuous variables were compared using the Wilcoxon rank-sum test and categorical variables using Fisher's exact test. Results: Postoperative RHF occurred in 25 of 79 patients (32%). Baseline demographic and clinical characteristics did not differ significantly between RHF and non-RHF groups. Compared with patients without RHF, those with RHF had longer pre-implant length of stay (14 vs 10 days, Conclusions: Postoperative RHF occurred in one-third of patients after durable LVAD implantation and was associated with significantly greater perioperative resource utilization. T-VAD was the predominant temporary RV support strategy at our institution and was feasible, with favorable observed survival in this descriptive single-center experience. Differences across support modalities likely reflect distinct clinical phenotypes and indications rather than a device effect and should not be interpreted as comparative evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.